Articles related toLetters to the Editor

Response to “Tocilizumab therapy and COVID-19”

Pallavi Bhargava, MD
J Osteopath Med; 121(11): 867-868

Embracing industry sponsored research to expand osteopathic medical student research experiences

Zachary P. Morehouse, OMS IV, MS; and Rodney J. Nash, PhD
J Osteopath Med; 121(12): 915-916

Tocilizumab therapy and COVID-19

Rujittika Mungmunpuntipantip, PhD; and Viroj Wiwanitkit, MD
J Osteopath Med; 121(11): 865

Progressive Idea for Osteopathic Medical Education

Daniel H. Belsky, DO, MSc
J Osteopath Med; 106(5): 303-304

Osteopathic Physicians and Disaster Relief

Brian Kloss and Matthew J. Levy
J Osteopath Med; 106(5): 306-306

Osteopathic Manipulative Treatment is for All DOs

Charles H. Cummings, DO
J Osteopath Med; 106(5): 305-305

Time to Accept Allopathic Physicians Into AOA-Approved Residencies?

Kenneth J. Steier, DO, MHA
J Osteopath Med; 106(5): 250-252

Will the Last DO Turn Off the Lights?

George Mychaskiw, DO
J Osteopath Med; 106(5): 252-302

Response to “Will the Last DO Turn Off the Lights?”

Michael I. Opipari, DO
J Osteopath Med; 106(5): 304-304

Follow Precautions When Prescribing Opioids

J. Jerry Rodos, DO, DSc
J Osteopath Med; 106(4): 220-220